
Loading, please wait...

Loading, please wait...

Max Healthcare Institute Ltd has officially joined an international research consortium under the Indo-EU COMBAT initiative. This dengue research initiative aims to strengthen global preparedness for mosquito-borne diseases. Supported by the Department of Biotechnology and the European Commission, the project brings together elite institutions from India and Europe. Consequently, they aim to develop technology-driven approaches for understanding, diagnosing, and managing dengue.
The consortium secured a major research grant to study disease progression. Specifically, researchers will focus on identifying early warning markers to improve patient outcomes. Representing Max Healthcare are principal investigators Sandeep Budhiraja and Atul Thatai. Furthermore, Ujjwal Neogi from the Karolinska Institute facilitated this collaboration. The BRIC National Institute of Biomedical Genomics leads the Indian effort. Because dengue remains a significant health concern, this project integrates multi-omics technologies and artificial intelligence. This combination helps researchers identify predictive biomarkers for earlier diagnosis.
Dengue continues to pose a major public health challenge in tropical regions. Therefore, partnerships that combine clinical expertise with advanced research are essential. Dr. Budhiraja noted that these collaborations strengthen early diagnosis and improve patient response strategies. Similarly, Dr. Neogi highlighted the importance of data-driven solutions. Moreover, these innovations help build stronger surveillance and treatment frameworks. As a result, the initiative advances global pandemic preparedness through cross-border scientific cooperation.
Q1: What is the primary goal of the Indo-EU COMBAT initiative?
The primary goal is to strengthen dengue research and improve global preparedness for mosquito-borne diseases through collaborative research and technology-driven approaches.
Q2: How will multi-omics and AI be used in this research?
The program will combine multi-omics technologies, clinical data, and artificial intelligence to better understand how dengue progresses and identify predictive biomarkers for earlier clinical interventions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Max Healthcare joins Indo-EU COMBAT initiative to advance dengue research using multi-omics and AI for early diagnosis and better patient outcomes....
3 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today